• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Adrian P. L. Smith, M. Marino, +6 authors Paul M. Evans
  • Medicine
  • Radiology
  • 2017 (First Publication: 1 March 2017)
  • Purpose To measure the levels of gadolinium present in the rat brain 1 and 20 weeks after dosing with contrast agent and to determine if there are any histopathologic sequelae. Materials and MethodsExpand
  • Christopher J. Buckley, Paul F. Sherwin, Adrian P. L. Smith, Jan Wolber, Sharon M. Weick, David J. Brooks
  • Medicine
  • Nuclear medicine communications
  • 2017 (First Publication: 16 December 2016)
  • Objectives An electronic training programme (ETP) was developed for interpretation of images during routine clinical use of the PET amyloid imaging agent [18F]flutemetamol injection (VIZAMYL). ThisExpand
  • Dietmar Rudolf Thal, Thomas G Beach, +5 authors Christopher Buckley
  • Medicine
  • Alzheimer's & Dementia
  • 2015 (First Publication: 1 August 2015)
  • BACKGROUND Amyloid positron emission tomography (PET) has become an important tool to identify amyloid-β (Aβ) pathology in Alzheimer's disease (AD) patients. Here, we determined the diagnostic valueExpand
  • S. Salloway, J. Gamez, +24 authors C. Curtis
  • Psychology, Medicine
  • Alzheimer's & dementia
  • 2017 (First Publication: 1 July 2017)
  • Introduction Performance of the amyloid tracer [18F]flutemetamol was evaluated against three pathology standard of truth (SoT) measures including neuritic plaques (CERAD “original” and “modified” andExpand
  • Ville Leinonen, Juha O. Rinne, +7 authors Igor D. Grachev
  • Medicine
  • Acta neuropathologica communications
  • 2014 (First Publication: 22 April 2014)
  • IntroductionPET imaging of amyloid-β (Aβ) in vivo holds promise for aiding in earlier diagnosis and intervention in Alzheimer’s disease (AD) and mild cognitive impairment. AD-like Aβ pathology is aExpand